Philipp Müller about Nicotine Vaccines

Philipp Müller is  Executive Vice President Clinical Development of Cytos Biotechnology. He talks about  nicotine vaccines. LISTEN

Philipp Müller, MD, has been Executive Vice President Clinical Development of Cytos Biotechnology since March 2003. He received his MD from the University of Basel and also holds a Clinical Pharmacologist SKP degree of the Swiss Society for Clinical Pharmacology.

He joined Cytos Biotechnology from Novartis Pharma AG, where he was Global Head of Clinical Pharmacology Scientists and Deputy of Global Head Clinical Pharmacology. He brings more than 20 years of experience in human pharmacology and clinical research to Cytos Biotechnology.

Philipp Müller, MD, has been Executive Vice President Clinical Development of Cytos Biotechnology since March 2003. He received his MD from the University of Basel and also holds a Clinical Pharmacologist SKP degree of the Swiss Society for Clinical Pharmacology.

He joined Cytos Biotechnology from Novartis Pharma AG, where he was Global Head of Clinical Pharmacology Scientists and Deputy of Global Head Clinical Pharmacology. He brings more than 20 years of experience in human pharmacology and clinical research to Cytos Biotechnology.